Evidence for SCID-Repopulating Cell Activity of CD34-Negative Cells by Intra-Bone Marrow

Evidence for SCID-Repopulating Cell Activity of CD34-Negative Cells by Intra-Bone Marrow

<p> 1</p><p>1Supplementary Information:</p><p>2Supplement Figure Legends:</p><p>3Figure S1. The limit of detection of human CD45+ cells in mouse BMs by FCM.</p><p>4In order to confirm the limit of detection of human CD45+ cells in mouse BMs by flow</p><p>5cytometry, we made test samples using mouse whole BM cells and human CB-derived</p><p>6mononuclear cells. The mixing ratios of murine to human cells were as follows: 0:100,</p><p>750:50, 90:10, 99.9:0.1, 99.99:0.01, 99.995:0.005 and 100:0. As clearly seen, we were</p><p>8able to detect 0.005% human CD45+ cells in the test samples. Based on these results, we</p><p>9scored the mice as positive if more than 0.01% of the total murine BM cells were</p><p>10human CD45+ cells. </p><p>11</p><p>12Figure S2. Screening of candidate positive markers for CB-derived CD34- SRCs</p><p>13(A) Candidate positive markers, including known HSC markers and various adhesion</p><p>14molecules, were screened by multicolor FCM using highly purified CB-derived 18Lin-</p><p>15CD34+/- cells. Known HSC markers, including Tie2, KDR, ABCG2, and CD150 were</p><p>16not expressed on these 18Lin-CD34+/- cells. On the other hand, CD133, c-kit, CD90,</p><p>17CXCR4, CD49f and CD93 were expressed on these 18Lin-CD34+/- cells. Back-gated</p><p>18scattergrams of the positive fractions of the above-mentioned markers, including</p><p>19CD133, c-kit, CD90, CXCR4, CD49f and CD93, in the 18Lin-CD34- cells were made</p><p>20into FSC/SSC dot grams. Each of the back-gated cells is shown in red (B). The blast-</p><p>21lymphocyte windows are shown by solid blue lines.</p><p>22</p><p>23Figure S3. The expression levels of lineage markers in the cocultures of 18Lin-</p><p>24CD34+/-CD133+/- cells with DP MSCs.</p><p>2 1 3</p><p>25The expression of CD33 (A), CD11b (B), CD14 (C), and CD41 (D) was analyzed by</p><p>26FCM. The percentages of positive cells are shown by solid columns. Each coculture</p><p>27contained six wells. The data represent the means ± SD. The statistical analysis was</p><p>28performed using two-tailed Student’s t-test. **P <0.01, n.s., not significant</p><p>29 </p><p>30Figure S4. The secondary multi-lineage reconstitution abilities of CD34+CD133+</p><p>31and CD34- CD133+ SRCs.</p><p>32First, the R1 gate was set on the total murine BM cells obtained from these two</p><p>33representative NOG mice that received (A) CD34+CD133+ SRCs (upper column) and</p><p>34(B) CD34- CD133+ SRCs (lower column) 18 weeks after secondary transplantation.</p><p>35Then the living cells were gated as R2. Thereafter, the human CD45+ cells were gated as</p><p>36R3 (solid line). The expression of surface markers, including CD33 and CD19, on the</p><p>37R3-gated cells was analyzed by multicolor FCM. The percentages of positive cells in</p><p>38each scattergram are indicated.</p><p>39</p><p>40Figure S5. The expression patterns of CD93 and CD133 on Lin-CD45+CD34-</p><p>41CD38hi/lo/- cells and 18Lin-CD34-CD38 hi/lo/- cells. </p><p>42The expression patterns of CD93 and CD133 on Lin-CD45+CD34-CD38hi/lo/- cells and</p><p>4318Lin-CD34-CD38hi/lo/- cells were precisely analyzed by seven-color FCM. In this</p><p>44experiment, we used FITC-conjugated 18 Lin mAbs, Brilliant Violet 421-conjugated</p><p>45anti-CD34, PE-Cy7-conjugated anti-CD38, Brilliant Violet 510-conjugated anti-CD45,</p><p>46PE-conjugated anti-CD93, APC-conjugated anti-CD133 mAbs and 7-AAD (see Table</p><p>47S1). (A) The forward scatter/side scatter (FSC/SSC) profile of the immunomagnetically</p><p>48separated Lin- cells. The R1 gate was set on the blast-lymphocyte window. (B) The R2</p><p>49gate was set on the living cells. (C) The R3 gate was set on the human CD45+ cells. (D)</p><p>4 2 5</p><p>50The Lin-CD45+ cells were subdivided into three fractions: Lin-CD45+CD34+/-CD38hi</p><p>51(R4), Lin-CD45+CD34+/-CD38lo (R5), and Lin-CD45+CD34+/-CD38- (R6), according to</p><p>52their expression levels of CD38. (E) The Lin-CD34+/-CD38hi cells residing in the R4 gate</p><p>53were further subdivided into two fractions: Lin-CD38hiCD34-CD93+ (R7) and Lin-</p><p>54CD38hiCD34-CD93- (R8) cells. (F) The Lin-CD34+/-CD38lo cells residing in the R5 gate</p><p>55were further subdivided into two fractions: Lin-CD38loCD34-CD93+ (R9) and Lin-</p><p>56CD38loCD34-CD93- (R10) cells. (G) The Lin-CD34+/-CD38- cells residing in the R6 gate</p><p>57were further subdivided into two fractions: Lin-CD38-CD34-CD93+ (R11) and Lin-CD38-</p><p>58CD34-CD93- (R12) cells. (H) The Lin-CD38hi CD34-CD93+ (R7) cells were further</p><p>59subdivided into three fractions: 18Lin-CD38hi CD34-CD93+CD133+ (R13), 18Lin-</p><p>60CD38hiCD34-CD93+ CD133- (R14), and 18Lin+CD38hi CD34-CD93+ CD133- (R15) cells.</p><p>61(I) The Lin-CD38hiCD34-CD93- (R8) cells were further subdivided into three fractions:</p><p>6218Lin-CD38hi CD34-CD93- CD133+ (R16), 18Lin-CD38hi CD34-CD93-CD133- (R17),</p><p>63and 18Lin+CD38hiCD34-CD93- CD133- (R18) cells. (J) The Lin-CD38loCD34-CD93+</p><p>64(R9) cells were further subdivided into three fractions: 18Lin-CD38loCD34-</p><p>65CD93+CD133+ (R19), 18Lin-CD38loCD34-CD93+CD133- (R20), and</p><p>6618Lin+CD38loCD34-CD93+ CD133- (R21) cells. (K) The Lin-CD38loCD34-CD93- (R10)</p><p>67cells were further subdivided into three fractions: 18Lin-CD38loCD34-CD93-CD133+</p><p>68(R22), 18Lin-CD38loCD34-CD93-CD133-(R23), and 18Lin+CD38loCD34-CD93-CD133-</p><p>69(R24) cells. (L) The Lin-CD38-CD34-CD93+ (R11) cells were further subdivided into</p><p>70three fractions: 18Lin-CD38-CD34-CD93+CD133+ (R25), 18Lin-CD38-CD34-</p><p>71CD93+CD133- (R26), and 18Lin+CD38-CD34-CD93+ CD133- (R27) cells. (M) The Lin-</p><p>72CD38-CD34-CD93- (R12) cells were further subdivided into three fractions: 18Lin-</p><p>73CD38-CD34-CD93-CD133+ (R28), 18Lin-CD38-CD34-CD93-CD133-(R29) and</p><p>7418Lin+CD38-CD34-CD93-CD133- (R30) cells. The Lin-CD45+CD34-CD38-CD93+ (R11)</p><p>6 3 7</p><p>75cells (Bonnet’s study) did not express CD133, as they reported. However, almost all of</p><p>76these cells were included in the 18Lin+ cell fraction. On the other hand, 18Lin-CD34-</p><p>77CD38lo/-CD133+ (R22 and R28) cells (this study) were only detected in the CD93- cell</p><p>78fraction (R10 and R12). The percentages of the cells are indicated in each of the</p><p>79scattergrams.</p><p>8 4</p>

View Full Text

Details

  • File Type
    pdf
  • Upload Time
    -
  • Content Languages
    English
  • Upload User
    Anonymous/Not logged-in
  • File Pages
    4 Page
  • File Size
    -

Download

Channel Download Status
Express Download Enable

Copyright

We respect the copyrights and intellectual property rights of all users. All uploaded documents are either original works of the uploader or authorized works of the rightful owners.

  • Not to be reproduced or distributed without explicit permission.
  • Not used for commercial purposes outside of approved use cases.
  • Not used to infringe on the rights of the original creators.
  • If you believe any content infringes your copyright, please contact us immediately.

Support

For help with questions, suggestions, or problems, please contact us